Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of atomoxetine
administered once daily in the treatment of adolescents with ADHD after 8 weeks and after 52
weeks